These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30568427)

  • 61. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
    Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B;
    Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
    Stass H; Delesen H; Nagelschmitz J; Staab D
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The pharmacological treatment of bronchiectasis.
    Melani AS; Lanzarone N; Rottoli P
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):245-258. PubMed ID: 29268637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.
    Orriols R; Roig J; Ferrer J; Sampol G; Rosell A; Ferrer A; Vallano A
    Respir Med; 1999 Jul; 93(7):476-80. PubMed ID: 10464834
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bronchiectasis and inhaled tobramycin: A literature review.
    Elborn JS; Blasi F; Haworth CS; Ballmann M; Tiddens HAWM; Murris-Espin M; Chalmers JD; Cantin AM
    Respir Med; 2022 Feb; 192():106728. PubMed ID: 34998112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Inhaled antibiotics for the management of non cystic fibrosis bronchiectasis].
    Berra G; Chappuis-Gisin É; Soccal PM; Plojoux J
    Rev Med Suisse; 2017 Nov; 13(583):2001-2004. PubMed ID: 29143505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response to inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa.
    Riveiro V; Casal A; Álvarez-Dobaño JM; Lourido T; Suárez-Artime P; Rodríguez-García C; Ferreiro L; Toubes ME; Valdés L
    Clin Respir J; 2022 Nov; 16(11):768-773. PubMed ID: 36017771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
    Gjoerup J; Hilberg O; Bendstrup E
    Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis.
    Rayner CF; Tillotson G; Cole PJ; Wilson R
    J Antimicrob Chemother; 1994 Jul; 34(1):149-56. PubMed ID: 7961201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.
    Murray MP; Govan JR; Doherty CJ; Simpson AJ; Wilkinson TS; Chalmers JD; Greening AP; Haslett C; Hill AT
    Am J Respir Crit Care Med; 2011 Feb; 183(4):491-9. PubMed ID: 20870753
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis.
    Khalid M; Saleemi S; Zeitouni M; Al Dammas S; Khaliq MR
    Ann Saudi Med; 2004; 24(4):284-7. PubMed ID: 15387496
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis.
    White L; Mirrani G; Grover M; Rollason J; Malin A; Suntharalingam J
    Respir Med; 2012 Mar; 106(3):356-60. PubMed ID: 22204744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.
    Maselli DJ; Amalakuhan B; Keyt H; Diaz AA
    Int J Clin Pract; 2017 Feb; 71(2):. PubMed ID: 28238229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.